El Salvador vs Guatemala: Prevalence rate of hypertension in men aged 30-79
El Salvador
31.4
in 2019
Guatemala
31.5
in 2019
El Salvador rank
162nd
Guatemala rank
161st
Prevalence rate of hypertension in men aged 30-79 over time
- El Salvador
- Guatemala
How they compare
Guatemala currently reports 31.5 against 31.4 in El Salvador, a difference of 0.1.
The two have swapped places 1 time across 30 shared years of data; in 1990 it was El Salvador ahead.
El Salvador ranks 162nd and Guatemala ranks 161st of 195 countries.
El Salvador has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | El Salvador | Guatemala | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 28.57 | 27.72 | 0.85 | El Salvador |
| 2000s | 30.64 | 29.73 | 0.91 | El Salvador |
| 2010s | 31.43 | 31.15 | 0.28 | El Salvador |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence rate of hypertension in men aged 30-79, El Salvador or Guatemala?
- Guatemala, at 31.5 against 31.4 in El Salvador as of 2019.
- What is the difference in prevalence rate of hypertension in men aged 30-79 between El Salvador and Guatemala?
- 0.1, with Guatemala ahead.
- How many years of comparable data are there for El Salvador and Guatemala?
- 30 years are reported by both, from 1990 to 2019.
- How do El Salvador and Guatemala rank globally for prevalence rate of hypertension in men aged 30-79?
- El Salvador ranks 162nd and Guatemala ranks 161st of 195 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Prevalence rate of hypertension in men aged 30-79. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated share of male population with hypertension, based on population representative surveys and statistical modeling. Hypertension is a risk factor for chronic complications, including cardiovascular disease, and premature death.